345 related articles for article (PubMed ID: 26222980)
1. Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.
Kolek MJ; Patel NJ; Clair WK; Whalen SP; Rottman JN; Kanagasundram A; Shen ST; Saavedra PJ; Estrada JC; Abraham RL; Ellis CR
J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1111-6. PubMed ID: 26222980
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
[TBL] [Abstract][Full Text] [Related]
3. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.
Bloom HL; Constantin L; Dan D; De Lurgio DB; El-Chami M; Ganz LI; Gleed KJ; Hackett FK; Kanuru NK; Lerner DJ; Rasekh A; Simons GR; Sogade FO; Sohail MR;
Pacing Clin Electrophysiol; 2011 Feb; 34(2):133-42. PubMed ID: 20942819
[TBL] [Abstract][Full Text] [Related]
4. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
[TBL] [Abstract][Full Text] [Related]
5. Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX™ antibacterial envelope.
Boriani G; Vitolo M; Wright DJ; Biffi M; Brown B; Tarakji KG; Wilkoff BL
Europace; 2021 Jun; 23(23 Suppl 4):iv33-iv44. PubMed ID: 34160600
[TBL] [Abstract][Full Text] [Related]
6. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
[TBL] [Abstract][Full Text] [Related]
7. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.
Chaudhry U; Borgquist R; Smith JG; Mörtsell D
Europace; 2022 Dec; 24(12):1973-1980. PubMed ID: 35989511
[TBL] [Abstract][Full Text] [Related]
10. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.
Kolek MJ; Dresen WF; Wells QS; Ellis CR
Pacing Clin Electrophysiol; 2013 Mar; 36(3):354-61. PubMed ID: 23252988
[TBL] [Abstract][Full Text] [Related]
11. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
[TBL] [Abstract][Full Text] [Related]
12. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
[TBL] [Abstract][Full Text] [Related]
13. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
[TBL] [Abstract][Full Text] [Related]
14. Nonstaphylococcal infections of cardiac implantable electronic devices.
Viola GM; Awan LL; Darouiche RO
Circulation; 2010 May; 121(19):2085-91. PubMed ID: 20439783
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular implantable electronic device infections in left ventricular assist device recipients.
Riaz T; Nienaber JJ; Baddour LM; Walker RC; Park SJ; Sohail MR
Pacing Clin Electrophysiol; 2014 Feb; 37(2):225-30. PubMed ID: 23998684
[TBL] [Abstract][Full Text] [Related]
16. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone-Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis.
Manolis AS; Melita H
Pacing Clin Electrophysiol; 2017 Jan; 40(1):26-34. PubMed ID: 27996097
[TBL] [Abstract][Full Text] [Related]
18. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
[TBL] [Abstract][Full Text] [Related]
19. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.
Tarakji KG; Korantzopoulos P; Philippon F; Biffi M; Mittal S; Poole JE; Kennergren C; Lexcen DR; Lande JD; Seshadri S; Wilkoff BL
Heart Rhythm; 2021 Dec; 18(12):2080-2086. PubMed ID: 34280568
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of antibacterial envelope in prevention of cardiovascular implantable electronic device infections in high-risk patients: A systematic review and meta-analysis.
Ullah W; Nadeem N; Haq S; Thelmo FL; Abdullah HM; Haas DC
Int J Cardiol; 2020 Sep; 315():51-56. PubMed ID: 32291170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]